Assisted reproductive technologies: new guidance for women and doctors is welcome

Robson, Stephen J; de Costa, Caroline M

doi:10.5694/mja17.00449

Topics

A new approach better informs women and doctors about what assisted reproductive technologies can achieve in 2017

Since the first Australian conceived by in vitro fertilisation (IVF) was born in 1980, this and other assisted reproductive technologies (ARTs) have come a long way in scope, availability, and success rates. About 4% of all Australian births are now made possible by ART,1 equivalent to one child in every classroom.

1 Centenary Hospital for Women and Children, Canberra, ACT
2 Australian National University, Canberra, ACT
3 James Cook University, Cairns, QLD

Correspondence: caroline.decosta@jcu.edu.au

Competing interests:

Stephen Robson is a paid member of the Medical Benefits Schedule Review and provides in vitro fertilisation services, but does not own any shares in an IVF unit.

1. Australian Institute of Health and Welfare. Australia’s mothers and babies 2013 — in brief (AIHW Cat. No. PER 72; Perinatal Statistics Series No. 31). Canberra: AIHW, 2015.
2. Chambers GM, Huang VP, Sullivan EA, et al. The impact of consumer affordability on access to assisted reproductive technologies and embryo transfer practices: an international analysis. Fertil Steril 2014; 101: 191-198.
3. Clark A. National fertility study 2006. Australians’ experience and knowledge of fertility issues (PowerPoint). www.fertilitysociety.com.au/wp-content/uploads/preservation-of-fertility-presentation-2006.ppt#1 (accessed May 2017).
4. Boivin J, Bunting L, Collins J, Nygren K. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007; 22: 1506-1512.
5. Collins J. Cost-effectiveness of in vitro fertilization. Semin Reprod Med 2001; 19: 279-290.
6. Mladovsky P, Sorenson C. Public financing of IVF: a review of policy rationales. Health Care Anal 2010; 18: 113-128.
7. Chambers GM, Zhu R, Hoang V, Illingworth PJ. A reduction in public health funding for fertility treatment — an econometric analysis of access to treatment and savings to government. BMC Health Serv Res 2012; 12: 142.
8. Chambers GM, Hoang VP, Illingworth PJ. Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs. Hum Reprod 2013; 28: 3111-3117.
9. Chambers GM, Paul RC, Harris K, et al. Assisted reproductive technology in Australia and New Zealand: cumulative live birth rates as measures of success. Med J Aust 2017; 207: 114-118.
10. Dahdouh EM, Balayla J, Audibert F, et al. Technical update: preimplantation genetic diagnosis and screening. J Obstet Gynaecol Can 2015; 37: 451-463.
11. Australian Institute of Health and Welfare. 25 years of health expenditure in Australia 1989–0 to 2013–14 (AIHW Cat. No. HWE 63; Health and Welfare Expenditure Series No. 56). Canberra: AIHW, 2016.
12. Boxall A. What are we doing to ensure the sustainability of the health system? (Research paper no. 4, 2011–12). Parliamentary Library, 18 Nov 2011. http://www.aph.gov.au/About_Parliament/Parliamentary_Departments/Parliamentary_Library/pubs/rp/rp1112/12rp04 (accessed May 2017).

Online responses are no longer available. Please refer to our instructions for authors page for more information.